Gluconeogenic pathways: Gluconeogenesis is the synthesis of glucose from three carbon precursors such as alanine, pyruvate, lactate, and glycerol and is essentially a reversal of glycolysis. Under normal conditions, 90% of gluconeogenesis occurs in liver, and the rest occurs mainly in the renal cortex. Other sites of gluconeogenesis, such as the small intestine have been suggested but remain controversial.
Read More »Yearly Archives: 2017
March 25, 2017
Most of the time when we speak about patients who are not diagnosed with diabetes and who develop complications, we are usually referring to vision changes or things like neuropathy. However, it now appears that there are a good number of these undiagnosed who die from ketoacidosis. This week, our …
Read More »“Normal” Urine Albumin to Creatinine Ratios Can Still Predict CV Risk
New evidence questions the idea of what is normal.
Read More »Use of Liraglutide in Obese Patients May Reduce Risk for Type 2 Diabetes
A new finding from the SCALE trial.
Read More »Weight-Loss Surgery Leads to Diabetes Remission
Gastric bypass surgery may treat type 2 diabetes in selected patients.
Read More »Serum Metabolites Affect Kidney in Type 1 Diabetes
Changes in serum metabolomic profile affect eGFR in patients with type 1 diabetes.
Read More »Role of Genomic Variance to Belly Fat in Diabetes
Genetic predisposition to a higher waist-to-hip ratio may lead to diabetes.
Read More »Use of Dietary Sugars or Glucose Tablets in Correcting Hypoglycemia
Proponents may suggest an advantage of one over the other, but the data is not so clear.
Read More »Question #878
The diabetes drug empagliflozin reduces all of the following CV risk factors except: a. Blood pressure b. Visceral adiposity c. Low-density lipoprotein cholesterol d. Triglycerides e. Atrial stiffness Follow the link to see if you got it right!
Read More »Physician-Assisted Suicide
Should physicians be able to help patients end their lives? Follow the link to share your opinion and see what your colleagues say.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.